4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-23-002144
Options or other derivatives
- Chief Legal Officer, Corp Sec. acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lim Bryant David Chief Legal Officer, Corp Sec. | 2023-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | D | ||
Loading xslF345X03/primarydocument.xml…